Literature DB >> 8604004

Endogenously produced urokinase amplifies tumor necrosis factor-alpha secretion by THP-1 mononuclear phagocytes.

R G Sitrin1, S B Shollenberger, R M Strieter, M R Gyetko.   

Abstract

This study examined the effects of endogenous urokinase (uPA) on lipopolysaccharide (LPS)-stimulated tumor necrosis factor alpha (TNF-alpha) secretion in THP-1 mononuclear phagocytes. Anti-uPA monoclonal antibody (mAb) suppressed LPS-driven TNF-alpha secretion by 61.6 +/- 5.9% (P<.001), and PAI-1, a uPA inhibitor, suppressed it to 53.1 +/- 8.2% of the control value (P<.001). Up-regulation of TNF-alpha mRNA was suppressed in parallel with secreted TNF-alpha protein. TNF-alpha secretion was unaffected by depleting plasminogen or by aprotinin, a plasmin inhibitor. When endogenous uPA was displaced from the cell, exogenous high-molecular-weight (intact) uPA augmented LPS-driven TNF-alpha secretion. By contrast, a uPA fragment containing the catalytic domain was inhibitory, and the uPA receptor-binding domain had no effect. We conclude that endogenous uPA amplifies TNF-alpha neosynthesis of LPS-stimulated THP-1 mononuclear phagocytes. The effect requires intact uPA and is independent of plasmin activity. This represents a novel mechanism by which a mononuclear phagocyte-derived protease contributes to generating proinflammatory signals.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8604004     DOI: 10.1002/jlb.59.2.302

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  11 in total

1.  Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. A murine transgenic model.

Authors:  M R Gyetko; G H Chen; R A McDonald; R Goodman; G B Huffnagle; C C Wilkinson; J A Fuller; G B Toews
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

2.  Remodeling of the vessel wall after copper-induced injury is highly attenuated in mice with a total deficiency of plasminogen activator inhibitor-1.

Authors:  V A Ploplis; I Cornelissen; M J Sandoval-Cooper; L Weeks; F A Noria; F J Castellino
Journal:  Am J Pathol       Date:  2001-01       Impact factor: 4.307

3.  The development of bleomycin-induced pulmonary fibrosis in mice deficient for components of the fibrinolytic system.

Authors:  C M Swaisgood; E L French; C Noga; R H Simon; V A Ploplis
Journal:  Am J Pathol       Date:  2000-07       Impact factor: 4.307

4.  Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.

Authors:  Andrew D Cook; Emma L Braine; Ian K Campbell; John A Hamilton
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

5.  4G/5G plasminogen activator inhibitor-1 polymorphisms and haplotypes are associated with pneumonia.

Authors:  Sachin Yende; Derek C Angus; Jingzhong Ding; Anne B Newman; John A Kellum; Rongling Li; Robert E Ferrell; Joseph Zmuda; Stephen B Kritchevsky; Tamara B Harris; Melissa Garcia; Kristine Yaffe; Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2007-08-29       Impact factor: 21.405

6.  4G/5G polymorphism of plasminogen activator inhibitor-1 gene is associated with mortality in intensive care unit patients with severe pneumonia.

Authors:  Anil Sapru; Helen Hansen; Temitayo Ajayi; Ron Brown; Oscar Garcia; HanJing Zhuo; Joseph Wiemels; Michael A Matthay; Jeanine Wiener-Kronish
Journal:  Anesthesiology       Date:  2009-05       Impact factor: 7.892

7.  Post-transcriptional regulation of urokinase-type plasminogen activator receptor expression in lipopolysaccharide-induced acute lung injury.

Authors:  Yashodhar P Bhandary; Thirunavukkarasu Velusamy; Praveenkumar Shetty; Rashmi S Shetty; Steven Idell; Douglas B Cines; Deepika Jain; Khalil Bdeir; Edward Abraham; Yuko Tsuruta; Sreerama Shetty
Journal:  Am J Respir Crit Care Med       Date:  2008-11-21       Impact factor: 21.405

8.  UV irradiation induces the murine urokinase-type plasminogen activator gene via the c-Jun N-terminal kinase signaling pathway: requirement of an AP1 enhancer element.

Authors:  F Miralles; M Parra; C Caelles; Y Nagamine; J Félez; P Muñoz-Cánoves
Journal:  Mol Cell Biol       Date:  1998-08       Impact factor: 4.272

9.  Urokinase-type plasminogen activator in inflammatory cell recruitment and host defense against Pneumocystis carinii in mice.

Authors:  J M Beck; A M Preston; M R Gyetko
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

10.  Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury.

Authors:  Anil Sapru; Martha A Q Curley; Sandra Brady; Michael A Matthay; Heidi Flori
Journal:  Intensive Care Med       Date:  2009-10-24       Impact factor: 17.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.